Atlas Trials

A Safety and Effective Study of Ginkgolides Diterpene Lactone Meglumine Injection in the Treatment of Ischemic Stroke.

Clinical trial NCT02526225 · COMPLETED

Trial details

NCT number
NCT02526225
Sponsor
Beijing Tiantan Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ischemic Stroke
Start date
2016-02-01
Primary completion
2018-05-01
Enrollment
3452

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.